Brüggemann, M.

leukemia protein fusion rearrangement patient t-cell assay detection lymphoblastic leukemia analysis immunobead result disease bcr-abl clonality blood sample department lymphoma lymphoblastic treatment fication clonal antibody assessment malignancy study transcript fusion proteins laboratory university technique group biomed diagnosis immunobead assay t-cell malignancies sensitivity european bcr –abl protocol pathology target table trial fl ow cytometry level mrd assessment protease rq-pcr multiplex van dongen jjm figure receptor trials m bruggemann breakpoint method cell lines bruggemann dongen signal childhood value adult cytometric leukemic cells esg-mrd-all myeloid mfi values inhibitor lysate m-bcr research quanti myeloid leukemia cytometry chromosome control marker leukemic